The enhanced UK-Switzerland FTA provides greater certainty on IP rights and exclusivity, supports cross-border collaboration and investment and streamlines talent mobility for pharma and biotech innovators.
A patent does not automatically grant the right to commercialise. Discover how competitor patent watching helps deep-tech businesses identify risks, monitor rivals and prepare for future freedom-to-operate reviews.
The UAE now permits trade mark filings for alcoholic beverages in Class 33 and beer in Class 32, aligning more closely with NICE Classification standards and offering stronger protection for brands.
A comparison of UPC and EPO jurisdiction, examining early UPC decisions on competence, long-arm jurisdiction, infringement, validity challenges and cross-border patent disputes.
As circular beauty gains momentum, cosmetics brands are investing in refill systems, sustainable materials and new product formats.
Discover why some of the most valuable patents in advanced materials, batteries, chemicals and green technologies emerge during scale-up from lab success to commercial manufacturing.
Learn the key differences between EPO oppositions and UPC revocation actions, from filing windows and procedural timelines to costs, scope and strategic considerations when challenging European patents.
Launching overseas? Discover six common trade mark pitfalls businesses face when entering Spain, Latin America and beyond.
From ownership and licensing to patents and publications, effective IP strategy is vital for university spin-outs. Learn how to protect innovation and support commercial success.
The Enlarged Board’s G 1/25 decision confirms description amendments are only needed where unresolved inconsistencies with the claims cause non-compliance with the EPC.
